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Introduction
Influenza is a highly infectious respiratory disease. It is 
generally benign, but may cause serious complications, 
especially in patients with chronic disease, the elderly, 
young children and pregnant women. The World Health 
Organisation (WHO) reports 3-5 million cases of influ-
enza annually [1]. Seasonal epidemics typically involve 
3 to 5% of the population, with peaks up to 10% depend-
ing on the size of the antigenic drift of viruses involved. 
Not only does influenza cause serious health problems, 
it also engenders high direct and indirect costs for so-
ciety as a whole [2]. During the 2009-2010 season, a 
new influenza virus, A/California/07/09, also called 
H1N1sv or H1N1v, spread throughout the world. Given 
the widespread circulation of this virus, its features and 
the vulnerability of the population (especially children 
and young people), international organizations (WHO) 
issued a phase-6 (pandemic) alert on June 11, 2009 [3].
Studies of evolutionary influenza genomics indicated 
that this new US strain had arisen as a result of reassort-
ment between two viruses present in pigs for some time:
• a pig virus strain H1N1 derived from a triple reas-
sortment, which incorporated RNA segments of hu-
man and avian influenza into its genome, this triple-
reassortant American strain had circulated in pigs 
for about 10 years without creating serious problems 
either for humans or for the animals themselves;
• a strain of the H1N1 swine virus of Eurasian lineage, 
which had long caused sporadic outbreaks of swine 
flu in farms in Europe and Asia, without human in-
volvement [4-6].
Once transmitted to humans, this new virus proved to be 
capable of causing disease clinically similar to “classi-
cal” influenza, and to be transmitted directly from per-
son to person through the air, like the previously known 
human flu viruses; the outbreak of these new viruses oc-
curred in North America.
Fortunately, the 2009 A/H1N1 influenza pandemic 
proved to be less deadly than had first been feared. In-
deed, in the opinion of many experts, the “severity” of 
the pandemic was mild, being slightly higher than that 
of seasonal influenza in the USA and Canada, though 
markedly higher in Mexico [7, 8].
During both epidemics and pandemics, strategies to mit-
igate and contain influenza rely on well-known effective 
non-pharmaceutical and pharmaceutical interventions, 
such as personal hygiene, wearing face-masks, quaran-
tine, social distancing and the administration of antiviral 
drugs and vaccines. Today, vaccination is the most ef-
fective means of preventing influenza and its potential 
complications [9, 10]. These strategies of containment 
and mitigation were described in the 2006 Italian Na-
tional Pandemic Preparedness and Response and Re-
sponse Plan prepared by the Directorate General for Pub-
lic Health in collaboration with the Influenza subgroup 
of the Centre for Disease Control (CCM). This plan 
also provided guidance for the preparation of regional 
plans, which were endorsed by almost all Regions [11]. 
In 2009, in response to the WHO’s phase-6 pandemic 
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Summary
Influenza is a cause of acute respiratory disease. It has a typical 
epidemic nature during the winter season, but may also assume 
a pandemic pattern when a completely new virus spreads among 
humans. Influenza places a heavy economic and healthcare bur-
den on both the National Health Service and society.
During the 2009/2010 influenza pandemic season, the Liguria 
Region drew upon the specific skills of the various sectors of the 
Department of Health and Social Services. In collaboration with 
the Department of Health Sciences of the University of Genova, 
the Regional Health Agency (RHA) and other public organiza-
tions, steps were taken to address the issues of technical and sci-
entific updating and the coordination of all the departments of 
Local Healthcare Units in Liguria.
The main activities conducted at the regional level provided an 
adequate response to the influenza pandemic. These activities 
focused on Local and National Influenza Surveillance Systems, the 
regional Pandemic Plan, vaccination strategies for seasonal and 
pandemic influenza, and the communication of data from monitor-
ing programs (sentinel physicians – syndromic surveillance).
The prevention of influenza transmission and containment of epi-
demics and pandemics require effective communication strategies 
that should target the whole population.
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alert, a National Crisis Management (NCM) Commit-
tee, headed by the Minister of Health, was created at the 
national level to choose the strategies to adopt regarding 
preparedness, response and communication [12].
During the 2009/2010 influenza pandemic season, the 
Liguria Region drew upon the specific skills of the various 
sectors of the Department of Health and Social Services. 
Specifically, the Sector of Prevention, Hygiene and Public 
Health, in collaboration with the Regional Health Agency 
(RHA) and other organizations, worked to address the is-
sues of technical and scientific updating and coordination, 
with specific reference to the various structures of Hy-
giene and Public Health Authorities operating in the area 
and direct calls to action in the event of a pandemic.
The main activities conducted at the regional level in 
order to provide an adequate response to the influenza 
pandemic are briefly described in the present article.
Local and National Surveillance Systems
The surveillance network of the Inter-university Centre for 
Research on Influenza and other Viral Infections (CIRI-
IV) is active in Genoa (Liguria, Northern Italy) and coor-
dinates other regions of Italy (Abruzzo, Calabria, Marche, 
Sicilia, Umbria, Lombardia, Friuli Venezia Giulia, Tosca-
na, Puglia, Campania). Based on sentinel surveillance, it 
combines clinical and virological information.
It plans, organizes and manages the network of clinical 
and epidemiological surveillance and assesses the im-
pact of influenza and acute respiratory diseases. It also 
promotes national and international research on influ-
enza and acute respiratory diseases, particularly with 
regard to etiology, epidemiology and prevention. More-
over, it monitors the isolation and identification of circu-
lating influenza viruses and their antigenic and genetic 
features. The centre collaborates with national scientific 
societies and research institutions that contribute to data 
collection (the National Institute of Health, the Italian 
Society of General Medicine, the Centers for Disease 
Control [CCM], Ministry of Health, Italian Federation of 
Medical Paediatrics [FIMP]), and is part of the European 
surveillance system coordinated by the WHO [13].
In particular, the CIRI-IV provides scientific support 
for the regional Public Health Services. During the 
2009/2010 pandemic season, weekly reports by the 
CIRI-IV were distributed to local stakeholders.
Since July 2007, the Liguria Region has funded a project, 
proposed by the Department of Health Sciences of the 
University of Genova, to implement a syndromic surveil-
lance system able to readily detect clusters of Influenza-
Like Illness (ILI) and Lower Respiratory Tract Infections 
(LRTI) through the analysis of data on admissions to the 
Emergency Department of a regional reference hospital, 
San Martino Hospital in Genoa [14]. Syndrome coding, 
data gathering, transmission and processing, statistical 
analysis to assess indicators of disease activity and alert 
thresholds, and signal response are systematically reg-
istered. The project also seeks to improve the system of 
communication with relevant institutions, including the 
Department of Health and Social Services of Liguria, 
the prevention departments of Local Health Agencies 
(LHA), hospitals and other institutions involved.
The system of feed-back includes periodic reports on 
early warnings sent by e-mail to the representatives and 
operators of the institutions involved.
During the pandemic, the CIRI-IV and syndromic surveil-
lance constituted an important system that monitored the 
local setting, providing relevant information on the spread 
of the influenza virus and morbidity in the population.
Regional Pandemic Plan
The Regional Plan for the organization of a health re-
sponse in the event of A/H1N1 pandemic influenza was 
promptly prepared (DGR n. 1255 of 21/09/2009) [15] and 
was distributed to healthcare managements and profes-
sionals directly involved in the field. The Regional Plan 
provided for joint actions applicable to the entire region 
and other response actions to be implemented directly 
by the healthcare facilities on regional management lists. 
This plan was aimed at strengthening preparedness and 
response by improving epidemiological and virological 
surveillance (identification, confirmation and daily report-
ing of cases), implementing containment measures at an 
early stage of a pandemic (isolation, border restrictions, 
probable/confirmed cases, contact tracing), and reducing 
the impact of the disease by applying pharmaceutical and 
hygiene measures. To determine an adequate emergency 
response, four phases of response were drawn up, and 
indicators for the progressive activation of specific ter-
ritorial surveillance activities were defined. Furthermore 
every LHA had prepared its plan.
Other measures applied
Briefly, the following joint actions were carried out at 
the regional level:
1. Vaccination strategies for seasonal  
and pandemic influenza
During the phase-6 pandemic alert, the active im-
munization strategies to be adopted in the 2009/2010 
season had to be revised in accordance with the pos-
sible co-circulation of the seasonal influenza virus and 
the new H1N1 virus. This eventuality raised the need 
to administer two vaccines: a trivalent vaccine con-
taining the strains A/Brisbane/59/2007 (H1N1)-like 
virus, A/Brisbane/10/2007 (H3N2)-like virus and B/
Brisbane/60/2008-like virus, and a monovalent vaccine 
against the new H1N1 variant, obtained by means of a 
reverse-genetics technique.
Once available, the pandemic vaccine was administered 
mostly through the vaccination service; the seasonal 
vaccine was administered by general practitioners, pae-
diatricians and the vaccination service. The Ministry of 
Health sent ordinances, recommendations and circulars 
on pandemic vaccination and target groups to the De-
partment of Health and Social Services of Liguria.
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schoolchildren (38.0% peak in November), while in the 
elderly, morbidity was very low. The Regional Surveil-
lance System extended its activity to monitoring the in-
cidence of medically attended ILI to identify the extent 
of the seasonal epidemic and collecting information on 
circulating viral strains from week 42 of 2009 to week 
17 of 2010.
The Regional Plan provided for joint actions applicable 
to the entire region and other response actions to be taken 
directly by the healthcare facilities on regional manage-
ment lists. The Regional Prevention Department applied 
vaccination strategies for seasonal and pandemic influ-
enza and monitored programs by means of syndromic 
surveillance and sentinel physicians.
The sector “Prevention, Hygiene and Public Health” 
worked with other agencies in the field to publicise 
measures to reduce the risk of transmission. In the fu-
ture, however, further research will be necessary to edu-
cate the public and to inform policy-makers as to what 
measures should be recommended and how they should 
be implemented [20]. Vaccination is undoubtedly the 
most efficacious means of providing protection against 
influenza infection. Nevertheless, the pandemic vac-
cines were not widely accepted by the population and 
health personnel. This could be explained by the manner 
of European Medicine Agency authorization (mock-up 
vaccine procedure and use of clinical data supporting the 
safety and effectiveness of vaccines developed from the 
influenza A/H5N1 strain) and the presence of adjuvant 
(MF59-squalene) [11].
Vaccination coverage by the first and second pandemic 
vaccine doses is shown in Table I. Coverage of 3.17% 
was achieved in subjects aged < 65 years and of 3.91% 
in those aged > 65 years in Liguria. Higher coverage 
rates were achieved in Liguria than in Italy as a whole 
among blood donors (7% vs. 0.8%) and subjects with at 
least one chronic underlying condition aged 6 months-
65 years (15% vs. 12.7%). By contrast, vaccine cover-
age was lower in Liguria than in Italy as a whole among 
chronic patients aged > 65 years (0.3% vs. 1.9%) and 
children aged < 6 months attending nursery/day care 
centres (0.4% vs. 5.2%). Vaccination coverage was not 
registered in the class “subjects younger than 24 months 
born preterm” in Liguria.
In sum, the Regional Action Plan, which was worked 
out in collaboration with LHA, was aimed at minimizing 
2. Communication of data of monitoring 
programs (sentinel physicians – syndromic 
surveillance)
Every region was required to send in weekly reports 
indicating the total numbers of probable, possible and 
confirmed cases and deaths due to pandemic influenza. 
Data communication was coordinated at the regional 
level, and newsletters dedicated to H1N1 influenza were 
prepared by RHA that provided updates on the epidemic 
and the most recent knowledge on the matter through 
downloads at http://www.arsliguria.it [16].
3. Hygiene measures to reduce the risk 
of transmission, and information on the 
prevention, surveillance and control of the 
pandemic
Hygiene recommendations were issued to the popula-
tion, especially schoolchildren, students, teachers, state 
employees etc. The most frequent advice was: to stay at 
home if ill, to wash hands often, especially after frequent-
ing public places (public transport, schools, hospitals, 
etc.), and to muffle coughs and sneezes with a handker-
chief or in the fold of the elbow. Self-diagnosis was also 
encouraged, so as not to overcrowd physicians’ offices.
4. Availability of antiviral drugs
The availability of specific drugs against the influenza vi-
rus is recognized as an important element in preparing the 
response to pandemic influenza [17, 18]. The Scientific 
Committee of the CCM, in collaboration with the Techni-
cal Committee of the Italian Drug Agency (AIFA), issued 
recommendations and opinions on the usefulness of anti-
viral drugs in a situation of pandemic influenza.
Antiviral drugs may be used to treat pandemic influenza, 
as they can mitigate the severity of the disease and re-
duce the risk of complications and death. They can also 
be used by people who have had close contact with a flu 
patient, and who may therefore have been infected. An-
tiviral drugs are useful in the early stages of a pandemic, 
or when the person exposed to the infection carries out 
public tasks, such as health care and assistance; they 
cannot be used for prophylaxis in general, as they are ef-
ficacious only when taken immediately before exposure 
or within 48 hours after contact.
On August 21, 2009, the WHO published guidelines on 
the use of antivirals for the treatment of patients who 
contracted the new H1N1 flu virus [19].
Results and discussion
The Regional Commission on Vaccines and Infectious 
Diseases and the Regional Pandemic Committee made 
important technical and scientific contributions to the 
field monitoring and management of the pandemic. The 
Liguria Region oversaw the vaccination campaign and 
managed the usability of antiviral drugs.
The pandemic period was characterized by an early epi-
demic peak (mid-October–mid-November) as reported 
in Figure 1. The highest incidence was observed in 
Fig. 1. morbidity x 1,000 inhabitants, influenza like illness for age 
class (data from Ciri-iv).
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the consequences of pandemic influenza. A multidisci-
plinary approach was adopted in order to implement in-
terventions in different phases, and updated information 
was promptly made available to decision-makers, health 
professionals, the media and the community. National 
and regional preparedness and response were the guid-
ing principles in tackling the influenza pandemic. The 
prevention of influenza transmission and containment of 
epidemics and pandemics require efficacious strategies 
that target the whole population.
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Tab. I. ligurian coverage of pandemic influenza vaccination by target group in the period october 2009 - april 2010.
Target groups Number of 
first doses 
administered 
in Liguria
Number of 
second doses 
administered 
in Liguria
Regional 
vaccine 
coverage
%
Number of 
first doses 
administered 
in Italy
Italian vaccine 
coverage
%
healthcare personnel 3,750 15 165,562 15.5
essential service personnel (armed 
forced)
1,219 4 72,181 5.9
blood donors 557 6,329 7 6,329 0.8
pregnant women in second or third 
trimesters
688 11 23,016 12.1
women who have delivered in the 
previous 6 months or persons who 
take care of babies
196 3.2 8,170 3.4
subjects with at least one chronic 
underlying condition aged 6 months-
65 years
11,775 1,148 15 549,167 12.7
subjects with at least one chronic 
underlying condition aged > 65 years
409 153 0.3 13,562 1.9
Children aged < 6 months who attend 
nursery/day care centres
25 19 0.4 4,618 5.2
Children living in communities 74 1 12 1,120 11.0
subjects younger than 24 months 
born preterm
11 3 - 1,595 7.7
persons 6 months-17 years 145 54 0.71 20,307 0.3
subjects 18-27 years 43 8 0.04 5,650 0.1
total 18,892 7,715 3.17 871,277 4.2
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